The Impact of Diabetes Mellitus on the Course of COVID-19 Pneumonia

For this purpose, we compared the demographic characteristics, symptoms, and signs of the disease, laboratory parameters, computerized tomography(CT) findings, and some data about the clinical course of the disease between two patient groups. Of 125 study participants, while 100 constituted the non-diabetic control group, 25 were grouped as the case or patient group diagnosed with DM. [...]in order to rule out the effects of other comorbidities, those with additional comorbidities were not included in both groups. The inclusion criteria were composed of the following: 1- Being over 18 years of age, 2- The determination of SARS-CoV-2 through the reverse transcription-polymerase chain reaction (RT-PCR) test taken from the respiratory tract swabs based on the guidelines of The Turkish Ministry of Health meeting the definition of probable cases, 3- The existence of significant involvement in chest tomography suggesting Covid-19 pneumonia, 4- No additional diseases other than DM in the case group with DM, 5- No additional diseases in the control group without DM, For patients' respiratory tract samples, the oropharyngeal swab samples were first taken and then the nasal samples were obtained using the same swab under the guidelines by The Turkish Ministry of Health. Among the laboratory parameters examined in the study, there was a statistically significant difference between both groups in terms of the values of gamma-glutamyl transferase (GGT), Creactive protein (CRP), white blood cell (WBC) count, neutrophil count, mean platelet volume (MPV), D-dimer and albumin.